|
Volumn 174, Issue 10, 2014, Pages 1612-1613
|
Improving safety of diabetes mellitus management
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CIPROFLOXACIN;
CLARITHROMYCIN;
COTRIMOXAZOLE;
HEMOGLOBIN A1C;
INSULIN;
LEVOFLOXACIN;
METRONIDAZOLE;
OPIATE DERIVATIVE;
ANTIINFECTIVE AGENT;
SULFONYLUREA DERIVATIVE;
DIABETES MELLITUS;
HEALTH CARE UTILIZATION;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
HYPOGLYCEMIA;
MEDICATION THERAPY MANAGEMENT;
NOTE;
PATIENT SAFETY;
PRESCRIPTION;
QUALITY OF LIFE;
CHEMICALLY INDUCED;
ECONOMICS;
FEMALE;
MALE;
ANTI-INFECTIVE AGENTS;
FEMALE;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
MALE;
SULFONYLUREA COMPOUNDS;
|
EID: 84908007422
PISSN: 21686106
EISSN: 21686114
Source Type: Journal
DOI: 10.1001/jamainternmed.2014.3290 Document Type: Note |
Times cited : (6)
|
References (8)
|